CN108530322B - Tyrosine semicarbazide hydrazone hydrochloride, its synthesis method and its use - Google Patents

Tyrosine semicarbazide hydrazone hydrochloride, its synthesis method and its use Download PDF

Info

Publication number
CN108530322B
CN108530322B CN201810496509.8A CN201810496509A CN108530322B CN 108530322 B CN108530322 B CN 108530322B CN 201810496509 A CN201810496509 A CN 201810496509A CN 108530322 B CN108530322 B CN 108530322B
Authority
CN
China
Prior art keywords
tyrosine
formula
compound represented
molar ratio
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810496509.8A
Other languages
Chinese (zh)
Other versions
CN108530322A (en
Inventor
赵新俊
孙利权
高汉荣
陈有刚
陈艳丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fule Ma Hongkai Dalian Medical Co ltd
Original Assignee
Fule Ma Hongkai Dalian Medical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fule Ma Hongkai Dalian Medical Co ltd filed Critical Fule Ma Hongkai Dalian Medical Co ltd
Priority to CN201810496509.8A priority Critical patent/CN108530322B/en
Publication of CN108530322A publication Critical patent/CN108530322A/en
Application granted granted Critical
Publication of CN108530322B publication Critical patent/CN108530322B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/06Compounds containing any of the groups, e.g. semicarbazides
    • C07C281/08Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones
    • C07C281/10Compounds containing any of the groups, e.g. semicarbazides the other nitrogen atom being further doubly-bound to a carbon atom, e.g. semicarbazones the carbon atom being further bound to an acyclic carbon atom or to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/16Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions not involving the amino or carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38618Protease or amylase in liquid compositions only
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38663Stabilised liquid enzyme compositions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention relates to a method for synthesizing tyrosine semicarbazide hydrazone hydrochloride. Specifically, the process comprises a) esterifying tyrosine to give an esterified intermediate 2; b) protecting the amino group and the phenolic hydroxyl group in the esterification intermediate 2 to obtain a compound represented by formula 3; c) reducing the compound represented by formula 3 to obtain a compound represented by formula 4; d) oxidizing the compound represented by formula 4 to obtain a compound represented by formula 5; e) reacting the compound represented by formula 5 with semicarbazide to obtain a compound represented by formula 6; f) deprotecting the compound represented by formula 6 to obtain tyrosine semicarbazone hydrochloride represented by formula 7; wherein R represents a methyl group, an ethyl group or a propyl group; r1Are protecting groups that can be used for both amino and phenolic hydroxyl groups. In addition, the invention also relates to the tyrosine semicarbazide hydrazone hydrochloride and application thereof.

Description

Tyrosine semicarbazide hydrazone hydrochloride, its synthesis method and its use
Technical Field
The invention relates to a protease stabilizer intermediate, in particular to a protease stabilizer intermediate tyrosine semicarbazone hydrochloride in a novel liquid detergent, and relates to a synthetic method of the intermediate tyrosine semicarbazone hydrochloride.
Background
In early liquid detergents, borides were typically added in order to maintain the protease activity in the detergent. Subsequent studies have shown boronThe compounds are degraded into boric acid, which is harmful to the environment. Later, danish novavissin (Novozymes) corporation developed a new protease stabilizer (WO 2013/004635, US 2014/0228274, and WO 2013/188344) in place of the boride. The novel protease stabilizer has a structure of X-B1-B0-H ", wherein X represents an amino acid or peptide bearing an N-terminal protecting group, B1Represents an amino acid, B0-H represents an aldehyde corresponding to an amino acid (abbreviated as aminoaldehyde).
It is well known that aminoaldehydes have been a difficult point of chemical synthesis. The chemical property of aldehyde is very active and easy to deteriorate, and the aldehyde can react with amino to generate Schiff base even under certain conditions. Particularly, the tyrosine corresponding aldehyde (casamino aldehyde for short) is an important intermediate of the novel protease stabilizer and shows better activity. However, there are few reports related to the synthesis of tyrosinal and its derivatives, and in the two prior art documents (BMCL,15(23),5176-5181, 2015; BMCL,18(1),95-98, 2008), the synthesis of tyrosinal and its derivatives was reported by the following route.
Figure BDA0001669071590000011
In the above route, it was mainly relied on to reduce the amide to the aldehyde at-78 ℃ with lithium aluminum hydride or diisobutylaluminum as the catalyst. Obviously, in the above-mentioned routes, the characteristics of flammability, high cost and necessity of low temperature use of the organoaluminum catalysts used greatly limit the industrial applicability of the existing reaction routes.
Further, firstly, the amino group of the amino aldehyde itself reacts with the aldehyde group and is difficult to be stably present. Secondly, the amino aldehyde derivatives obtained in the above routes have a protecting group at the amino group, which is not compatible with the protease stabilizer "X-B1- "are partially bound. Therefore, even if the aminoaldehyde derivative is obtained by a known route, it is difficult to obtain a desired protease stabilizer by a condensation reaction.
Therefore, there is a need for aminoaldehyde derivatives and methods for their synthesis as appropriate intermediates,which is suitable for the synthesis of "X-B1-B0-H "type protease stabilizers and are suitable for industrial production.
Disclosure of Invention
Therefore, the present invention aims to provide an intermediate suitable for producing protease stabilizers, and a synthetic method thereof suitable for industrial production.
For the above purpose, considering the properties of aldehyde group, amino group and the use of the desired intermediate, and considering that the protecting group used should be conveniently introduced and removed and stable under various conditions, the present invention employs semicarbazide to protect aldehyde group to obtain tyrosine semicarbazide hydrazone hydrochloride (H-Tyr-sec. hcl) as an intermediate, first, the resulting derivative is stable under conventional acidic, basic and amino acid condensation conditions, and tyrosine aminoaldehyde can be easily obtained by exchange using formaldehyde or benzaldehyde; secondly, the intermediate is structurally stable, easy to store and transport, and capable of reacting with "X-B1The condensation is carried out with high efficiency and no side reaction basically occurs.
Figure BDA0001669071590000021
Thus, according to one aspect of the present invention, there is provided a process for the synthesis of tyrosine semicarbazone hydrochloride, wherein the process is carried out according to the process scheme shown below, comprising:
Figure BDA0001669071590000031
a) esterifying tyrosine to obtain an esterified intermediate 2;
b) protecting the amino group and the phenolic hydroxyl group in the esterification intermediate 2 to obtain a compound represented by formula 3;
c) reducing the compound represented by formula 3 to obtain a compound represented by formula 4;
d) oxidizing the compound represented by formula 4 to obtain a compound represented by formula 5;
e) reacting the compound represented by formula 5 with semicarbazide to obtain a compound represented by formula 6;
f) deprotecting the compound represented by formula 6 to obtain tyrosine semicarbazone hydrochloride represented by formula 7;
wherein R represents a methyl group, an ethyl group or a propyl group; r1Is tert-butyloxycarbonyl, benzyloxycarbonyl, methoxycarbonyl or ethoxycarbonyl.
According to one embodiment, in step a), thionyl chloride or hydrogen chloride, preferably thionyl chloride, is used as catalyst. The molar ratio of the catalyst to the tyrosine is 1-3, preferably 1.2-1.5. In this step, the solvent is not particularly limited, and the esterifying reagent used may be used together as a solvent, and may be, for example, a lower alcohol such as methanol, ethanol or isopropanol, preferably methanol. After the reaction is complete, the product obtained can be used directly in step b).
According to one embodiment, step b) is carried out in the presence of a base, using a protecting reagent capable of simultaneously protecting the amino group and the phenolic hydroxyl group, such as di-tert-butyl dicarbonate, benzyl chloroformate, methyl chloroformate or ethyl chloroformate, preferably di-tert-butyl dicarbonate, and using a molar ratio of the protecting reagent to tyrosine of 2 to 5, preferably 2.2 to 2.5. Tetrahydrofuran, methanol, toluene, dichloromethane or ethyl acetate are used as solvents; the base used may be an organic or inorganic base such as triethylamine, diisopropylethylamine, sodium bicarbonate, potassium bicarbonate, sodium carbonate or potassium carbonate, preferably potassium carbonate. In a preferred embodiment, a di-tert-butyl dicarbonate, methylene chloride and potassium carbonate system is employed. The product obtained can be used directly in step c).
According to one embodiment, in step c), as reducing agent those compounds conventionally used in the art for reducing esters to alcohols may be used, such as borohydride, preferably sodium borohydride, potassium borohydride, zinc borohydride or calcium borohydride, more preferably sodium borohydride, wherein the molar ratio of reducing agent used to tyrosine is 1 to 4, preferably 1.8 to 2.2; the solvent used is tetrahydrofuran, methanol, ethanol, isopropanol or ethylene glycol dimethyl ether, preferably methanol. In a preferred embodiment, a sodium borohydride and methanol system is employed. The product obtained can be used directly in step d).
According to one embodiment, in step d), sodium hypochlorite is used as the oxidant, the molar ratio of the oxidant used to tyrosine being 1.5 to 3.0, preferably 1.8 to 2.2; using tetramethylpiperidine nitroxide and sodium bromide/potassium bromide as co-catalyst; ethyl acetate, methyl tert-butyl ether or dichloromethane, preferably ethyl acetate, is used as solvent. In a preferred embodiment, a sodium hypochlorite, tetramethylpiperidine nitroxide, sodium bromide and ethyl acetate system is employed. The product obtained can be used directly in step e).
According to one embodiment, in step e), the molar ratio of semicarbazide to tyrosine is between 0.8 and 1.5, preferably between 0.95 and 1.05. The solvent is not particularly limited, but dichloromethane, methyl t-butyl ether, ethyl acetate or toluene is preferably used, and ethyl acetate is more preferably used. The product obtained can be used directly in step f).
According to one embodiment, in step f), trifluoroacetic acid, methanesulfonic acid, p-toluenesulfonic acid or hydrogen chloride is used as deprotecting reagent, wherein the molar ratio of deprotecting reagent to tyrosine used is 3 to 10, preferably 5 to 6; the solvent used is not particularly limited, and may be, for example, a lower alcohol such as methanol, ethanol, isopropanol, or dichloromethane. In a preferred embodiment, a hydrogen chloride and methanol system is employed.
In a particularly preferred embodiment of the invention, this is carried out by way of the following schematic representation:
Figure BDA0001669071590000041
a) carrying out esterification reaction on tyrosine and methanol under the action of thionyl chloride to obtain an esterification intermediate L-Tyr-OMe.HCl;
b) reacting the esterified intermediate L-Tyr-OMe.HCl with di-tert-butyl dicarbonate in the presence of potassium carbonate to obtain the di-Boc ester intermediate Boc-Tyr (Boc) -OMe;
c) reacting the double Boc ester intermediate Boc-tyr (Boc) -OMe with sodium borohydride to obtain the double Boc alcohol intermediate Boc-tyr (Boc) -olo;
d) reacting the double Boc alcohol intermediate Boc-tyr (Boc) -olo with sodium hypochlorite to obtain double Boc aldehyde intermediate Boc-tyr (Boc) -H;
e) reacting the double Boc aldehyde intermediate Boc-Tyr (Boc) -H with semicarbazide to give a double Boc semicarbazide hydrazone intermediate Boc-Tyr (Boc) -SEC;
f) reacting the double Boc semicarbazide hydrazone intermediate Boc-Tyr (Boc) -SEC with a strong acid to obtain tyrosine semicarbazide hydrazone hydrochloride H-Tyr-SEC.
In the process of the present invention, all of the raw materials are readily available on the market. Through six steps of high-yield reaction, except that the final product needs to be purified to obtain a solid, the intermediates in other steps do not need to be subjected to a fine purification step, the loss of the intermediates and the use of a large amount of purification solvents are reduced, and the process is simple and convenient and is easy for industrial continuous production. The final product can be used to produce protease stabilizers by a reaction that is easy to perform.
Drawings
FIG. 1 is a chart showing a HPLC chart of the reaction in step a) in preparation example 1 according to the present invention; wherein the retention time of L-tyrosine is 2.86 minutes, and the retention time of L-tyrosine methyl ester is 3.03 minutes;
FIG. 2 is a chart showing a reaction HPLC spectrum in step b) in preparative example 1 according to the present invention; wherein the retention time of the L-tyrosine methyl ester is 3.03 minutes; the retention time of Boc-Tyr (Boc) -OMe was 16.4 min;
FIG. 3 is a chart showing a reaction HPLC spectrum in step c) in preparative example 1 according to the present invention; wherein the Boc-Tyr (Boc) -OMe retention time is 16.4 minutes; the retention time of Boc-Tyr (Boc) -OLO was 13.5 min;
FIG. 4 is a chart showing a reaction HPLC spectrum in step d) in production example 1 according to the present invention; wherein the retention time of Boc-Tyr (Boc) -olo was 13.2 minutes; the retention time of Boc-Tyr (Boc) -H was 12.7 minutes;
FIG. 5 is a chart showing a reaction HPLC spectrum in step e) in preparative example 1 according to the present invention; wherein the retention time of Boc-Tyr (Boc) -H is 12.7 minutes, the retention time of Boc-Tyr (Boc) -SEC is 11.7 minutes, and the retention time of Boc-Tyr-SEC is 6.1 minutes;
FIG. 6 is a chart showing a reaction HPLC chart in step f) in production example 1 according to the present invention; wherein the retention time of Boc-Tyr (Boc) -H is 12.7 minutes, the retention time of Boc-Tyr (Boc) -SEC is 11.7 minutes, and the retention time of Boc-Tyr-SEC is 6.1 minutes;
FIG. 7 is an HPLC chromatogram showing tyrosine semicarbazone hydrochloride in step f) of preparation example 1 according to the present invention;
FIG. 8 is a diagram showing tyrosine semicarbazone hydrochloride in step f) of preparation example 1 according to the present invention1H NMR spectrum.
Detailed Description
In the corresponding synthetic method provided by the invention, tyrosine which is a simple and cheap starting material is adopted, the tyrosine semicarbazone hydrochloride is produced with high yield under mild reaction conditions, the post-treatment method is simple, and an intermediate in each step is not required to be solidified and purified, so that the method is very suitable for commercial scale-up production.
As can be seen from the following specific examples, the method of the present invention has stable yield and high product purity through hundreds of gram-scale experiments. The process is easy to be amplified and is suitable for commercial amplification production.
The invention will be further illustrated below by particularly preferred synthetic routes. It should be understood by those skilled in the art that the present invention is not limited to the following specific embodiments. The reaction raw materials, catalysts, solvents and the like used in the following preparation examples are commercially available.
The reaction was monitored by HPLC during the reaction, wherein the peak numbers appearing in the table below were determined in terms of the order of appearance of the peaks. The HPLC (Agilent 1200) test conditions are as follows:
column: kromasil C18250X 4.6mm 5 μm
Column temperature: 25 deg.C
Detection wavelength: 210nm
Flow rate: 1mL/min
Sample introduction amount: 2 μ L
Operating time: 30min
Mobile phase A: 0.1% TFA/water (1 mL of TFA was added to 1000mL of water and mixed well)
Mobile phase B: acetonitrile
0min:70%A,30%B
10min:30%A,70%B
Preparation example 1: synthesis of tyrosine semicarbazide hydrazone hydrochloride
Step a): 136 g of tyrosine and 680 ml of anhydrous methanol are mixed under nitrogen protection, and 107 g of thionyl chloride is added dropwise at room temperature. Then the solution is heated to 57 ℃ to 63 ℃ and reacted for 2 hours. Then, the mixture was concentrated under reduced pressure at this temperature to obtain a suspension, and 100 ml of toluene was added to the suspension to obtain a suspension. This suspension was used directly in the next step.
The integration results of this step by HPLC are shown in Table 1 below.
TABLE 1
Figure BDA0001669071590000071
Step b): adding the suspension obtained in the step a) into 750 ml of dichloromethane, cooling to 0-5 ℃, adjusting the pH value of the system to 8-9 by using a potassium carbonate aqueous solution, and then dropwise adding 380 g of di-tert-butyl dicarbonate. Stirred and reacted at room temperature. After the reaction was completed, the mixture was allowed to stand, separated, and the organic phase was concentrated under reduced pressure at 40 ℃ to obtain 300 g of a pale yellow oil.
The integration results of this step by HPLC are shown in Table 2 below.
TABLE 2
Figure BDA0001669071590000072
Figure BDA0001669071590000081
Step c): 300 g of the yellow oil obtained in step b) are added to 500 ml of anhydrous methanol, and after stirring the mixture evenly, 57 g of sodium borohydride are added in portions. At this time, heat was released and a large amount of bubbles were generated. The reaction system is reacted for 1 hour at 30-35 ℃. After the reaction is finished, 500 ml of toluene is added, and then the citric acid aqueous solution is dropwise added to adjust the pH value of the reaction system to 3-4. After standing and separating, the toluene phase was concentrated under reduced pressure at 40 ℃ to give 380 g of an oil.
The integration results of this step by HPLC are shown in Table 3 below.
TABLE 3
Figure BDA0001669071590000082
Step d): 380 g of the yellow oil obtained in step c) are added to 2 l of ethyl acetate, and after stirring the mixture uniformly, 60 g of sodium bicarbonate, 800 ml of water, 8 g of sodium bromide and 2 g of tetramethylpiperidine nitroxide are added in turn. The system was cooled to 0 ℃ and 1.2 liters of an aqueous sodium hypochlorite solution was added dropwise while the system temperature was kept below 5 ℃. After the addition was complete, the mixture was stirred at a temperature of less than 5 ℃ for 1 hour. After the reaction is finished, standing and separating liquid. The organic phase was washed with 200 ml of saturated aqueous sodium bicarbonate solution and 200 ml of 5% aqueous citric acid solution in this order. The organic phase was concentrated under reduced pressure at 40 ℃ to give 280 g of an oil.
The integration results of this step by HPLC are shown in Table 4 below.
TABLE 4
Figure BDA0001669071590000083
Figure BDA0001669071590000091
Step e): 280 g of the oil obtained in step d) are added to 1.5 l of ethyl acetate and, after stirring to homogeneity, the semicarbazide hydrochloride and the aqueous solution of sodium bicarbonate prepared beforehand are added. The system was allowed to react at 20 ℃ to 25 ℃ for 2 hours. After the reaction was completed, the mixture was allowed to stand, separated, and the organic phase was concentrated under reduced pressure to obtain 260 g of a pale yellow oil.
The integration results of this step by HPLC are shown in Table 5 below.
TABLE 5
Figure BDA0001669071590000092
Step f): 260 g of the oil obtained in step e) are added to 800 ml of anhydrous methanol, and 118 g of hydrogen chloride gas are then introduced. The system was allowed to react at 20 ℃ to 25 ℃ for 24 hours. After the reaction was complete, the reaction was concentrated at 40 ℃ under reduced pressure to give an oil. Then, 800 ml of methyl t-butyl ether was added and a large amount of solid was precipitated. Filtration and drying in vacuo at 40 ℃ gave 112 g of a pale yellow solid. By HPLC and1the product was identified by H NMR as tyrosine semicarbazide hydrazone hydrochloride in 99.7% chemical purity. The total yield of the six steps is 57.8 percent by calculation.
The integration results of this step by HPLC are shown in Table 6 below.
TABLE 6
Figure BDA0001669071590000093
Preparation example 2: synthesis of tyrosine semicarbazide hydrazone hydrochloride
Step a): 272 g of tyrosine and 1.4 l of anhydrous methanol are mixed under nitrogen and 200 g of thionyl chloride are added dropwise at room temperature. The resulting solution was then heated to 57 ℃ to 63 ℃ and reacted for 2 hours. Then, the mixture was concentrated under reduced pressure at this temperature to obtain a suspension, and 200 ml of toluene was added thereto, followed by concentration again to obtain a suspension. This suspension was used directly in the next step.
Step b): adding the suspension obtained in the step a) into 1.5L of toluene, cooling to 0-5 ℃, adjusting the pH value of the system to 8-9 by using a potassium carbonate aqueous solution, and then dropwise adding 765 g of di-tert-butyl dicarbonate. Stirred and reacted at room temperature. After the reaction was completed, the mixture was allowed to stand, separated, and the organic phase was concentrated under reduced pressure at 40 ℃ to obtain 610 g of a pale yellow oil.
Step c): 610 g of the yellow oil obtained in step b) are added to 1 l of absolute ethanol and, after stirring to homogeneity, 110 g of sodium borohydride are added in portions. At this time, heat was released and a large amount of bubbles were generated. The reaction system is reacted for 1 hour at 30-35 ℃. After the reaction is finished, 1 liter of toluene is added, and then a citric acid aqueous solution is dropwise added to adjust the pH value of the reaction system to 3-4. After standing and separating the phases, the toluene phase was concentrated under reduced pressure at 40 ℃ to give 780 g of an oil.
Step d): 780 g of the yellow oil obtained in step d) are added to 4 l of methyl tert-butyl ether, and after stirring the mixture to homogeneity, 120 g of sodium bicarbonate, 1.6 l of water, 16 g of sodium bromide and 5 g of tetramethylpiperidine nitroxide are added in this order. The system was cooled to 0 ℃ and 2.5 liters of an aqueous sodium hypochlorite solution were added dropwise while the system temperature was kept below 5 ℃. After the addition was complete, the mixture was stirred at a temperature of less than 5 ℃ for 1 hour. After the reaction is finished, standing and separating liquid. The organic phase was washed successively with 400 ml of saturated aqueous sodium bicarbonate solution and 400 ml of 5% aqueous citric acid solution. The organic phase was concentrated under reduced pressure at 40 ℃ to give 580 g of an oil.
Step e): 580 g of the oil obtained in step d) are added to 3 l of ethyl acetate and, after stirring to homogeneity, the semicarbazide hydrochloride and the aqueous solution of sodium bicarbonate prepared beforehand are added. The system was allowed to react at 20 ℃ to 25 ℃ for 2 hours. After the reaction was completed, the mixture was allowed to stand, separated, and the organic phase was concentrated under reduced pressure to obtain 560 g of a pale yellow oil.
Step f): 560 g of the oil obtained in step e) are added to 1.6 l of anhydrous methanol, and 218 g of hydrogen chloride gas are then introduced. The system was allowed to react at 20 ℃ to 25 ℃ for 24 hours. After the reaction was complete, the reaction was concentrated at 40 ℃ under reduced pressure to give an oil. Then, 1.6L of methyl t-butyl ether was added, and a large amount of solid was precipitated. Filtration and drying in vacuo at 40 ℃ gave 212 g of a pale yellow solid. The obtained product is tyrosine semicarbazone hydrochloride through verification, and the chemical purity is 99.6%. The total yield of the six steps is 54.6 percent.

Claims (18)

1. A method of synthesizing tyrosine semicarbazone hydrazone hydrochloride, wherein the method comprises:
Figure FDA0002647465330000011
a) esterifying tyrosine to obtain an esterified intermediate 2;
b) protecting the amino group and the phenolic hydroxyl group in the esterification intermediate 2 to obtain a compound represented by formula 3;
c) reducing the compound represented by formula 3 to obtain a compound represented by formula 4;
d) oxidizing the compound represented by formula 4 to obtain a compound represented by formula 5;
e) reacting the compound represented by formula 5 with semicarbazide to obtain a compound represented by formula 6;
f) deprotecting the compound represented by formula 6 to obtain tyrosine semicarbazone hydrochloride represented by formula 7;
wherein R represents a methyl group, an ethyl group or a propyl group; r1Is tert-butyloxycarbonyl, benzyloxycarbonyl, methoxycarbonyl or ethoxycarbonyl.
2. The process according to claim 1, wherein in step a), thionyl chloride or hydrogen chloride is used as catalyst; wherein the molar ratio of the catalyst to the tyrosine is 1-3.
3. The process according to claim 2, wherein in step a) thionyl chloride is used as catalyst.
4. The process according to claim 2, wherein in step a) the molar ratio of catalyst to tyrosine used is from 1.2 to 1.5.
5. The method according to claim 1, wherein step b) is carried out in the presence of a base, wherein di-tert-butyl dicarbonate, benzyl chloroformate, methyl chloroformate or ethyl chloroformate is used as a protecting reagent, and the molar ratio of the protecting reagent to tyrosine used is 2-5; the base used is triethylamine, diisopropylethylamine, sodium bicarbonate, potassium bicarbonate, sodium carbonate or potassium carbonate.
6. The process according to claim 5, wherein in step b) di-tert-butyl dicarbonate is used as protecting agent.
7. The method according to claim 5, wherein in step b) the molar ratio of the protecting reagent to tyrosine used is 2.2-2.5.
8. The method according to claim 1, wherein in step c), borohydride is used as a reducing agent, and the molar ratio of the reducing agent to tyrosine is 1-4; tetrahydrofuran, methanol, ethanol, isopropanol or ethylene glycol dimethyl ether is used as a reaction solvent.
9. The process according to claim 8, wherein in step c) sodium borohydride, potassium borohydride, zinc borohydride or calcium borohydride is used as reducing agent.
10. The process according to claim 8, wherein in step c) the molar ratio of reducing agent to tyrosine used is between 1.8 and 2.2.
11. The process according to claim 8, wherein in step c) methanol is used as reaction solvent.
12. The method according to claim 1, wherein in step d), sodium hypochlorite is used as the oxidant, and the molar ratio of the oxidant to tyrosine is 1.5-3.0; using tetramethylpiperidine nitroxide and sodium bromide/potassium bromide as co-catalyst; ethyl acetate, methyl tert-butyl ether or dichloromethane was used as solvent.
13. The process according to claim 12, wherein in step d) the molar ratio of oxidant to tyrosine used is between 1.8 and 2.2.
14. The process according to claim 1, wherein in step e) the molar ratio of semicarbazide to tyrosine is between 0.8 and 1.5.
15. The process according to claim 14, wherein in step e) the molar ratio of semicarbazide to tyrosine is between 0.95 and 1.05.
16. The process according to claim 1, wherein in step f), trifluoroacetic acid, methanesulfonic acid, p-toluenesulfonic acid or hydrogen chloride is used as deprotecting reagent; the molar ratio of the deprotection reagent to tyrosine is 3-10.
17. The process of claim 1, wherein in step f), the molar ratio of deprotecting reagent to tyrosine is 5-6.
18. The method of claim 1, wherein R is methyl and R is1Is tert-butyloxycarbonyl.
CN201810496509.8A 2018-05-22 2018-05-22 Tyrosine semicarbazide hydrazone hydrochloride, its synthesis method and its use Active CN108530322B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810496509.8A CN108530322B (en) 2018-05-22 2018-05-22 Tyrosine semicarbazide hydrazone hydrochloride, its synthesis method and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201810496509.8A CN108530322B (en) 2018-05-22 2018-05-22 Tyrosine semicarbazide hydrazone hydrochloride, its synthesis method and its use

Publications (2)

Publication Number Publication Date
CN108530322A CN108530322A (en) 2018-09-14
CN108530322B true CN108530322B (en) 2020-11-06

Family

ID=63472401

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810496509.8A Active CN108530322B (en) 2018-05-22 2018-05-22 Tyrosine semicarbazide hydrazone hydrochloride, its synthesis method and its use

Country Status (1)

Country Link
CN (1) CN108530322B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113896761A (en) * 2021-09-15 2022-01-07 湖北泓肽生物科技有限公司 Synthetic method of L-tyrosyl-L-proline

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103649289A (en) * 2011-07-01 2014-03-19 诺维信公司 Liquid detergent composition
CN107848962A (en) * 2015-05-27 2018-03-27 杏林制药株式会社 Urea derivative or its pharmacologically acceptable salt

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103649289A (en) * 2011-07-01 2014-03-19 诺维信公司 Liquid detergent composition
CN107848962A (en) * 2015-05-27 2018-03-27 杏林制药株式会社 Urea derivative or its pharmacologically acceptable salt

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
1688689-66-8;CAS号;《STN》;20150421;1-4 *
Aliphatic and alicyclic aldehydes: synthesis by hydrolysis;Plietker.B.et al;《Science of Synthesis》;20071231(第25期);1-197 *
Step-Up Synthesis of Periodic Mesoporous Organosilicas with a Tyrosine Framework and Performance in Horseradish Peroxidase Immobilization;Wang Jianqiang et al;《Chemistry An Asian Journal》;20171231;第12卷(第24期);3162-3171 *
Submonomer synthesis of azapeptide ligands of the Insulin Receptor Tyrosine Kinase domain;David Sabatino et al;《Bioorganic & Medicinal Chemistry Letters》;20141231;第24卷;4176-4180 *

Also Published As

Publication number Publication date
CN108530322A (en) 2018-09-14

Similar Documents

Publication Publication Date Title
CN110183347B (en) Compound containing benzyl structure and application thereof
CN114181191B (en) Synthesis method of cyclic sulfate
US20200189991A1 (en) Process for the preparation of deuterated ethanol from d2
EP2816028B1 (en) Method for synthesizing ramalin by using a glutamic acid derivative and hydroxy aniline or hydroxy aniline having protected hydroxy group
CN108530322B (en) Tyrosine semicarbazide hydrazone hydrochloride, its synthesis method and its use
CN115724792A (en) Edoxaban key intermediate and synthesis method thereof
CN101081851B (en) Preparation method of alpha-aza toroid drug template
NZ587505A (en) Method for preparing combretastatin
ES2973718T3 (en) New process for the preparation of disodium (4s)-4-(4-ethoxybenzyl)-3,6,9-tris(carboxymethyl)-3,6,9-triazaundecanedioic acid gadolinium complex (disodium gadoxetate)
CN109369779B (en) Synthetic method of taltirelin
CN111533745A (en) Process for preparing tert-butyl-3- (aminomethyl) dihydro-5H-triazolodiazepine-8 (9H) -carboxylic acid ester
JP3561253B2 (en) Method for synthesizing aliphatic, cycloaliphatic or araliphatic chloroformates
CN109574860B (en) Method for preparing vilanterol
RU2620379C2 (en) Method for prepairing derivatives of 2-phenyl [1,2,4] triazolo [1,5-a] pyridine
EP1243576B1 (en) Processes for producing (aminomethyl)trifluoromethylcarbinol derivatives
CA2426466A1 (en) Phosgene-free process for preparing carbamates
CN113214255B (en) Synthesis method of 2, 6-diazaspiro [3.5] nonane-6-tert-butyl formate and salt thereof
CN114105961B (en) Preparation method of IDO1 inhibitor (LY-3381916)
CN115181077B (en) Synthesis method of vortioxetine with low impurity content
US20030004360A1 (en) Processes and intermediates for preparing benzyl epoxides
KR20120098686A (en) Processes for preparing a polymeric compound
KR20030033001A (en) Process for the preparation of 5-phenylpentanoyl-ala-argl-ala-[2-(3-amino-2-oxopyrrolidin-1-yl)propionyl]-ala-arg-ala-4-aminophenylacetamide
US9067868B2 (en) Chemical process for opening ring compounds
WO2024092892A1 (en) Edoxaban intermediate and preparation method therefor
CN114736186B (en) Method for synthesizing Violet Luo Zhongjian body from tert-butyl carbamate

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant